Steroid-Induced Ocular Hypertension in Normal Sheep

被引:60
|
作者
Gerometta, Rosana [2 ,3 ]
Podos, Steven M. [1 ,4 ]
Danias, John [1 ,4 ]
Candia, Oscar A. [1 ,5 ]
机构
[1] Mt Sinai Sch Med, Dept Ophthalmol, New York, NY 10029 USA
[2] Univ Nacl Nordeste, Dept Farmacol, Fac Med, Corrientes, Argentina
[3] Univ Nacl Nordeste, Dept Oftalmol, Fac Med, Corrientes, Argentina
[4] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA
[5] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA
基金
美国国家卫生研究院;
关键词
HUMAN TRABECULAR MESHWORK; DEXAMETHASONE; GLAUCOMA; CELLS; GLUCOCORTICOIDS; PHAGOCYTOSIS; MODULATION; GENE;
D O I
10.1167/iovs.08-2410
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. To determine whether the ovine eye develops elevation of intraocular pressure (IOP) in response to corticosteroid applied topically. METHODS. IOP was monitored by Perkins applanation tonometry in a group of 18 sheep receiving topically administered 0.5% prednisolone acetate in one eye (experimental), three times daily, for a period of 3 or four 4 weeks after the establishment of baseline IOP values. Perkins readings were converted to actual mm Hg using a calibration curve derived from in vivo manometric measurements. IOP was monitored for an additional 1 to 3 weeks after discontinuation of corticosteroid treatment. RESULTS. Baseline IOP in normal sheep was 10.6 +/- 1.4 mm Hg (mean +/- SD; n = 36 eyes). The IOP of the experimental eyes began to increase after 1 week of prednisolone treatment in all sheep and reached a peak 1 week later (27.5 mm Hg experimental vs. 11.7 mm Hg fellow, control eye; P < 0.001). After the discontinuation of corticosteroid instillation, the IOP of the treated eyes declined to the baseline values over the course of 1 to 3 weeks. CONCLUSIONS. Ovine eyes exhibit a robust steroid-induced ocular hypertensive response, with 100% occurrence in this trial. The mechanisms of steroid-induced glaucoma may be related to those involved in primary open-angle glaucoma and could provide insight into primary open-angle and clues to its treatment. (Invest Ophthalmol Vis Sci. 2009;50:669-673) DOI:10.1167/iovs.08-2410
引用
收藏
页码:669 / 673
页数:5
相关论文
共 50 条
  • [1] Steroid-induced ocular hypertension in normal cattle
    Gerometta, R
    Podos, SM
    Candia, OA
    Wu, B
    Malgor, LA
    Mittag, T
    Danias, J
    ARCHIVES OF OPHTHALMOLOGY, 2004, 122 (10) : 1492 - 1497
  • [2] STEROID-INDUCED OCULAR HYPERTENSION IN HIGH MYOPIA
    Wang Rong-fang
    Guo Bing-kuan
    CHINESEMEDICALJOURNAL, 1984, (01) : 28 - 28
  • [3] Predictive features of the steroid-induced ocular hypertension
    Min, Kyung Hyun
    Hyeob, Kim Jun
    Yeon, Gil Jin
    Lee, Kyung Eun
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 318 - 319
  • [4] STEROID-INDUCED OCULAR HYPERTENSION IN HIGH MYOPIA
    WANG, RF
    GUO, BK
    CHINESE MEDICAL JOURNAL, 1984, 97 (01) : 24 - 28
  • [5] Steroid-induced ocular hypertension after photorefractive keratectomy
    De Bernardo, Maddalena
    Salzano, Francesco Antonio
    Rosa, Nicola
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2018, 44 (01): : 118 - 118
  • [6] Higher incidence of steroid-induced ocular hypertension in keratoconus
    Anastasios John Kanellopoulos
    Emerson M. Cruz
    Robert Edward T. Ang
    George Asimellis
    Eye and Vision, 3
  • [7] Steroid-induced ocular hypertension in the pediatric age group
    Al Hanaineh, Abeer T.
    Hassanein, Dina H.
    Abdelbaky, Sameh H.
    El Zawahry, Omar M.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2018, 28 (04) : 372 - 377
  • [8] Higher incidence of steroid-induced ocular hypertension in keratoconus
    Kanellopoulos, Anastasios John
    Cruz, Emerson M.
    Ang, Robert Edward T.
    Asimellis, George
    EYE AND VISION, 2016, 3
  • [9] STEROID-INDUCED OCULAR HYPERTENSION IN PATIENTS WITH FILTERING BLEBS
    WILENSKY, JT
    SNYDER, D
    GIESER, D
    OPHTHALMOLOGY, 1980, 87 (03) : 240 - 244
  • [10] Risk factors of pediatric steroid-induced ocular hypertension
    Takano, Fumio
    Ueda, Kaori
    Yamada-Nakanishi, Yuko
    Nakamura, Makoto
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, : 867 - 872